[시장보고서]세계의 경두개 도플러 초음파 검사 시장(2023-2030년)

세계의 경두개 도플러 초음파 검사 시장(2023-2030년)

Global Transcranial Doppler Ultrasound Market - 2023-2030

상품코드 : 1345373

리서치사 : DataM Intelligence

발행일 : 2023년 09월

페이지 정보 : 영문 195 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,350

￦ 6,142,000

PDF & Excel (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,850

￦ 6,848,000

PDF & Excel (Multiple User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,850

￦ 11,084,000

PDF & Excel (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

시장 개요

세계의 경두개 도플러 초음파 검사 시장은 2022년에 2,730만 달러에 달하며, 2030년에는 4,300만 달러에 달할 것으로 예측되며, 예측 기간인 2023-2030년 CAGR은 6.7%로 성장할 전망입니다. 경두개 도플러 초음파 검사는 혈전, 혈관 협착 부위, 지주막하 출혈로 인한 혈관 경련, 미세 혈전으로 인한 뇌졸중을 감지합니다. 음파를 사용하여 뇌의 혈류에 영향을 미치는 의학적 문제를 감지하는 무통 검사입니다.

또한 질병의 유병률 증가는 경두개 도플러 초음파 시장 규모를 증가시킬 수 있습니다. 미국과 캐나다와 같은 국가의 의료 확대 가구가 증가함에 따라 시장은 북미에서 수요가 증가하고 있으며, Viasonix, Rimed, Dawei Medical과 같은 다른 주요 기업이 시장에서 활발하게 활동하고 있습니다.

시장 역학

겸상 적혈구증 환자 수의 증가가 시장 성장 촉진

겸상 적혈구 질환의 증가는 시장 성장을 높일 가능성이 있습니다. 예를 들어 겸상적혈구증(SCD)은 약 10만 명의 미국인이 앓고 있으며, 흑인 또는 아프리카계 미국인 출생아 365명 중 1명이 SCD를 앓고 있고, 히스패닉계 미국인 출생아 16,300명 중 1명이 SCD를 앓고 있습니다. 흑인 또는 아프리카계 미국인 아기 13명 중 1명은 겸상적혈구형질(SCT)을 가지고 태어납니다.

또한 경두개 도플러 초음파 검사는 일부 겸상적혈구증 어린이에게 필수적인 검사입니다. 뇌졸중은 겸상적혈구증(SCD)을 앓고 있는 소아에서 가장 심각한 합병증 중 하나이며, 소아의 약 5-10%에서 발생하며, 발병 시기는 생후 10년에 최고조에 달할 전망입니다. 이 검사는 소아의 뇌졸중 위험을 판단하는 데 도움이 됩니다. 따라서 겸상 적혈구 질환 증가는 시장 성장을 증가시킬 수 있습니다.

허혈성 뇌졸중 유병률 증가는 시장 성장을 가속화 할 수 있습니다.

허혈성 뇌졸중 유병률 증가는 시장 성장을 가속화할 수 있습니다. 예를 들어 미국에서는 매년 79만 명 이상이 뇌졸중을 앓고 있습니다. 이 중 약 61만 명은 초발 또는 신규 뇌졸중입니다. 약 18만 5,000명의 뇌졸중은 거의 4명 중 1명이 뇌졸중 기왕력자입니다. 전체 뇌졸중의 약 87%는 허혈성 뇌졸중으로, 뇌로 가는 혈류가 차단된 상태입니다.

혈전, 혈관 협착, 지주막하 출혈로 인한 혈관 경련, 미세 혈전 등으로 인한 뇌졸중을 발견할 수 있습니다. 경두개 도플러(TCD)는 급성 허혈성 뇌졸중 진단에 가장 유용한 툴 중 하나입니다. 미세색전, 뇌혈관 협착 정도, 측부혈관에 대한 귀중한 정보를 얻을 수 있습니다. 따라서 허혈성 뇌졸중 유병률 증가는 시장 성장을 증가시킬 수 있습니다.

TCD와 관련된 한계는 시장 성장을 저해할 수 있습니다.

TCD와 관련된 한계는 두개골 살서제에 정확한 동맥을 삽입하기 위한 기술적 문제입니다. 또한 고령자(급성 뇌졸중 환자의 12-19%)의 경우 두꺼운 두개골을 통해 초음파 에너지가 감쇠되기 때문에 도플러 파형을 얻기가 어려울 수 있습니다. 프레임 속도가 느리면 정보가 평균화되어 움직임이 느린 연부조직의 신호는 플래시 아티팩트로 나타납니다. 따라서 TCD와 관련된 한계는 시장 성장을 저해할 수 있습니다.

영문목차

Market Overview

The Global Transcranial Doppler Ultrasound Market reachedUS$ 27.3 million in 2022 and is expected to reach US$ 43.0 million by 2030, growing with a CAGR of 6.7% during the forecast period 2023-2030. Transcranial doppler ultrasound test detects stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, and tiny blood clots. It is a painless test that uses sound waves to detect medical problems that affect blood flow in the brain.

Furthermore, the increase in the prevalence of the diseases can elevate the transcranial doppler ultrasound market size. Due to the increase in healthcare expanditure in the countries like the U.S. and Canada, the market is experiencing an increase in demand in North American region. Significant key players like Viasonix, Rimed, Dawei Medical, and others are actively operating in the market.

Market Dynamics

Increase in the Number of Sickle Cell Diseases can Elevate the Market Growth

An increase in the number of sickle cell disorders can elevate the market growth. For instance, sickle cell diseases (SCD) affects approximately 100,000 Americans. SCD occurs among about 1 out of every 365 black or African-American births. SCD occurs among about 1 out of every 16,300 hispanic-American births. About 1 in 13 black or African-American babies is born with sickle cell trait (SCT).

Additionally, transcranial doppler ultrasound is an essential test for children with certain type of sickle cell disease. Stroke is one of the most severe complications in children suffering from sickle cell disease (SCD), affecting approximately 5-10% of children with an incidence peak in the first decade of life. This test can help determine the child's risk for stroke. Thus, an increase in the number of sickle cell diseases can elevate market growth.

Rise in the Prevalence of Ischemic Strokes can Accelerate Market Growth

The increase in the prevalence of ischemic strokes can elevate market growth. For instance, every year, more than 790,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes-nearly 1 in 4-are in people with a previous stroke. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.

It can detect stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, tiny blood clots, and more. Transcranial doppler (TCD) is one of the most useful tools in diagnosing acute ischemic stroke. It provides valuable information about microemboli, the degree of cerebral vessel stenosis, and collateral flow. Thus, an increase in the prevalence of ischemic strokes can raise market growth.

Limitations associated with the TCDs can HamperMarket Growth

The limitations associated with the TCDs are technical challenges to insonate the correct artery within the cranial vault. It may also be difficult to obtain doppler waveforms in elderly patients because of the attenuation of ultrasound energy through a thick skull typical in such patients (12-19% of patients with acute stroke). Because of more averaging of information at slower frame rates, slow-moving soft tissue signals appear as flash artifacts. Thus, the limitations associated with TCDs can hamper market growth.

Segment Analysis

The global transcranial doppler ultrasound market is segmented based on type, technology, application, end-user and region.

The Pulsed Wave Doppler Segment Accounted for Approximately 39.8% of the Transcranial Doppler Ultrasound Market Share.

The increase in the advancements of the products can expand the growth of the segment. For instance, on February 9, 2022, Royal Philips announced it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on the company's Lumify handheld point-of-care ultrasound device. The pulsed wave doppler (PW Doppler) sends short pulses of ultrasound and analyzes reflected sound waves between the pulses.

By sending short and quick pulses of sound, it accurately measures the velocity of blood in a precise location and in real time. The crystals alternate rapidly between sending and analyzing ultrasound. Thus, an increase in the advancements in the products is driving the growth of the segment.

Geographical Penetration

North America Accounted for Approximately 47.2% of the Market Share in 2022.

North America is expected to hold a significant position in the transcranial doppler ultrasound market share. Due to the increase in technological advancements, innovations, and launches, there is a growth of the market in this region. For instance, on March 4, 2021, EchoNous, the leading developer of AI-driven, hand-carried ultrasound, announced the addition of both continuous wave (CW) and pulsed wave (PW) doppler capabilities to the Kosmos hardware platform, the company's flagship offering.

This innovation represents an industry first for an ultra-mobile ultrasound product, creating the first "hybrid" point-of-care ultrasound (POCUS) device, offering extensive machine-benchmarked ultrasound imaging and doppler functionality in a hand-carried unit (HCU). Thus, an increase in technological advancements in the products and the launches is driving the growth of the market.

Competitive Landscape

The major global players in the transcranial doppler ultrasound market include Viasonix, Rimed, Dawei Medical, Konica Minolta Healthcare India Pvt. Ltd., NovoSignal Corp, Viasonix, Compumedics Germany GmbH, RIMED, Elekta AB, Shenzhen Delica Medical Equipment Co., Ltd. and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant influence on the transcranial doppler ultrasound market, posing unprecedented challenges to many countries. The delayed launches and innovations have shown a negative impact on the usage of transcranial doppler ultrasound. The reduced number of product approvals has reduced market growth. Thus, COVID-19 has declined the growth of the transcranial doppler ultrasound market.

By Type

Non-Duplex TCDs
Duplex TCDs

By Technology

Continuous wave Doppler
Pulsed Wave Doppler

By Application

Sickle Cell Disease
Acute Ischemic Stroke
Intracranial Steno Occlusive Disease
Vasospasm
Others

By End-User

Hospitals
Diagnostic Laboratories
Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

On February 28, 2023, NovaSignal announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA, in order to advance stroke research and use real-time neuromonitoring to detect and help prevent intraprocedural cardiovascular and neurovascular complications in the region.
On July 13, 2022, Delica is pleased to announce that they have begun serving the US market with the approval of the Transcranial Doppler EMS-9M by the US FDA. Most recent wireless TCD in the world is called EMS-9M. It is a battery-powered, battery-powered system. Both in sedentary and active modes, it can be used for cerebral evaluations as well as investigations of peripheral and microvascular regions.
On March 15, 2022, a medical technology and data company specializing in the assessment and management of brain health announced that its NovaGuide Intelligent Ultrasound has been granted a Medical Device Licence by Health Canada. NovaGuide is now available to Canadian healthcare practitioners for use in capturing and monitoring blood flow in the brain in real-time.

Why Purchase the Report?

To visualize the global transcranial doppler ultrasound market segmentation based on type, technology, application, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of transcranial doppler ultrasound market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available in Excel consisting of key products of all the major players.

The global transcranial doppler ultrasound market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in the Number of Sickle Cell Diseases
  - 4.1.1.2. Rise in the Prevalence of Ischemic Strokes
- 4.1.2. Restraints
  - 4.1.2.1. Limitations Associated with the TCDs
- 4.1.3. Opportunity
  - 4.1.3.1. Advancements in the Diagnostic Devices
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Non-Duplex TCDs
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Duplex TCDs

8. By Technology

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology
8.2. Continuous wave Doppler
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pulsed Wave Doppler

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Sickle Cell Disease
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Acute Ischemic Stroke
9.4. Intracranial Steno Occlusive Disease
9.5. Vasospasm
9.6. Others

10. By End-user

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.1.2. Market Attractiveness Index, By End-user
10.2. Hospitals
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Spain
  - 11.3.7.5. Italy
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Viasonix
- 13.1.1. Company Overview
- 13.1.2. ProductPortfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Rimed
13.3. Dawei Medical
13.4. Konica Minolta Healthcare India Pvt. Ltd.
13.5. NovoSignal Corp
13.6. Viasonix
13.7. Compumedics Germany GmbH
13.8. RIMED
13.9. Elekta AB,
13.10. Shenzhen Delica Medical Equipment Co., Ltd.

LIST NOT EXHAUSTIVE

14. Appendix

14.1. About Us and Services
14.2. Contact Us

한글목차

시장 개요

시장 역학

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

제5장 산업 분석

제6장 COVID-19 분석

제7장 유형별

제8장 기술별

제9장 용도별

제10장 최종사용자별

제11장 지역별

제12장 경쟁 구도

제13장 기업 개요

제14장 부록